Published: Jun 01, 2021, 05:00 IST | Updated: Jun 01, 2021, 05:00 IST
US drugmaker Pfizer on Monday formally authorized the use of its COVID-19 vaccine for around 4 million children age 12 to 15 in Japan, following similar moves overseas to allow adolescents to be vaccinated.